Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 76 publications
Safety and clinical outcomes of a first-in-human trial of point-of-care manufactured trispecific CAR T cells targeting CD19, CD20, and CD22.
Journal: Blood cancer discovery
Published: May 18, 2026
Integrative Molecular Analysis Reveals Determinants of Clinical Outcomes in TP53-Mutated Diffuse Large B-Cell Lymphoma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 29, 2026
Safety and clinical outcomes of a first-in-human trial of point-of-care manufactured trispecific CAR T cells targeting CD19, CD20, and CD22.
Journal: Research square
Published: February 23, 2026
Outcomes of patients with chronic lymphocytic leukemia discontinuing covalent Bruton tyrosine kinase inhibitors due to adverse events.
Journal: Leukemia
Published: December 07, 2025
SOHO State of the Art Updates and Next Questions | Richter Transformation in the Modern Era of Therapy.
Journal: Clinical lymphoma, myeloma & leukemia
Published: September 16, 2025
Cost impact of Bruton's tyrosine kinase inhibitor selection in Medicare patients with chronic lymphocytic leukemia.
Journal: Journal of comparative effectiveness research
Published: June 23, 2025
Prognostic Implication of Karyotypic Evaluation in Patients With Richter Transformation in the Modern Era.
Journal: American journal of hematology
Published: May 07, 2025
PKCβ Inhibitor MS-553 Displays Preclinical Efficacy in Both Treatment-Naïve and BTK Inhibitor-Resistant Chronic Lymphocytic Leukemia.
Journal: Blood cancer discovery
Published: April 02, 2025
Outcomes of patients with Richter transformation who received no prior chemoimmunotherapy for their CLL.
Journal: Blood cancer journal
Published: January 10, 2025
Cytokine Release Syndrome and Neurotoxicity Following CD19 CAR-T in B-Cell Lymphoma.
Journal: Transplantation and cellular therapy
Published: December 26, 2024
Last Updated: 09/26/2026